CLINICAL SUPPLY MANAGEMENT ARTICLES
The End Of Just-In-Time? Why Clinical Trial Supply Chains Are Rethinking Inventory Strategy
Clinical trials are too unpredictable for inventory strategies built on fixed assumptions. Learn why agility, visibility and smarter buffers are becoming essential to supply planning.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.
-
Flexible clinical development requires scalable infrastructure, strong project management, and global logistics to ensure supply continuity and regulatory compliance.
-
Since the FDA is now encouraging creativity in trial designs, it is important for all stakeholders to adapt processes to follow the science and ultimately bring medicines to patients, faster. This white paper addresses the complexities that come with these trial designs, and how randomization and trial supply management (RTSM) solutions are critical to run flexible, robust, and quality-driven trials.